A critical discovery in cancer study is emerging with the use of nanobodies to re-engage damaged p53. This essential cancer protector protein is frequently inactivated in various kinds of cancer, leading uncontrolled https://bookmarkfriend.com/story21991018/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-treatment